Web Access Research Portal

Researcher: de Graaff, B (Ms Barbara de Graaff)

Fields of Research

Health, Clinical and Counselling Psychology
Health Economics
Public Health and Health Services
Health Information Systems (incl. Surveillance)
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)
Primary Health Care
Health and Community Services
Gastroenterology and Hepatology
Infectious Diseases
Rheumatology and Arthritis
Clinical Pharmacology and Therapeutics
Haematology
Psychology and Cognitive Sciences
Pharmacology and Pharmaceutical Sciences
Health Promotion
Health Care Administration

Research Objectives

Substance Abuse
Public Health (excl. Specific Population Health)
Evaluation of Health Outcomes
Health Policy Evaluation
Expanding Knowledge in Psychology and Cognitive Sciences
Blood Disorders
Infectious Diseases
Health Policy Economic Outcomes
Health and Support Services
Palliative Care
Specific Population Health (excl. Indigenous Health)
Health
Behaviour and Health
Skeletal System and Disorders (incl. Arthritis)
Expanding Knowledge in the Medical and Health Sciences
Mental Health Services
Health Education and Promotion
Fixed Line Telephone Networks and Services

Career Best Publications

Research Publications

A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions; Osteoporosis International
A systematic review and narrative synthesis of health economic studies conducted for hereditary haemochromatosis; Applied Health Economics and Health Policy
After-hours GP home visits strain the budget (and don’t help emergency departments)
Alprazolam use in Tasmania: Is policy change kicking goals or behinds?; APSAD 2010 Conference
Australian Drug Trends 2006: Findings from the Illicit Drug Reporting System
Australian Drug Trends 2007: Findings from the Illicit Drug Reporting System
Barriers to Harm Reduction: Heating and Filtration of Oxycodone Tablets Prior to Intravenous Use by People Who Inject Drugs in Australia
Bumps, bruises and benzos: Factors associated with accidents amongh regular injecting drug users; APSAD 2009 Conference
Cost-effectiveness of different population screening strategies for hereditary haemochromatosis in Australia; Applied Health Economics and Health Policy
Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study; Australian Health Review
Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets; Harm Reduction Journal
Effects of Filtration on the Presence of Particulate and Oxycodone Content of Injections Prepared from Crushed OxyContin® Tablets; Current Drug Safety
Experience of non-viral injecting-related injuries and diseases amongst people who regularly inject drugs; APSAD 2012
Filtering pharmaceutical opioids for injection: What methods are being used and how effective are they?; APSAD Conference 2008
Health and Well-Being in Tasmanian Prisoners With and Without Hepatitis C Antibodies; APSAD 2011 Conference
Indicators of Drug Use in Tasmania
Injecting MS Contin: What is the harm reduction evidence?; APSAD 2009 Conference
Injecting OxyContin: What is the harm reduction eveidence?; ATDC 2010: Reducing harm across the lifespan
Need, want and demand: What is really happening with low-acuity presentations?; Emergency Medicine Australasia
NPS provision in prisons: Time to embrace the evidence; APSAD 2011 Conference
Old fits, new fits: Re-use of injecting equipment amongst a sample of regular injectiing drug users in Tasmania; APSAD 2010 Conference
Over the counter codeine use by people who inject drugs regularly in Australia; APSAD 2010 Conference
Pharmaceutical opioid injection in high and low heroin availability jurisdictions: the who and why; APSAD Conference 2008
PND10 – Cost-Effectiveness of Population Screening for Haemochromatosis In Australia: A State-Transition Model; Value in Health
PND9 – An Australian National Cost of Illness Study For Hereditary Haemochromatosis; Value in Health
Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model; PharmacoEconomics - Open
Predictors of sub-clinical paranoia among methamphetamine consumers; APSAD 2010 Conference
Pull the other one: Effects of the prescription restriction level for benzodiazepines in an isolated drug market; APSAD Conference 2008
Push to fight jail hepatitis
Quality of life utility values for hereditary haemochromatosis in Australia; Health and Quality of Life Outcomes
Reducing harm from pharmaceutical opioid injection: The importance and effectiveness of filters; APSAD 2010 Conference
Self-reported mental health problems amongst regular injecting drug users interviewed in the IDRS
Tasmania Drug Trends 2012: Findings from the Illicit Drug Reporting System (IDRS)
Tasmanian After-Hours Primary Care Service Innovations: A Report in Three Parts
Tasmanian After-Hours Primary Care: Evaluation of the GP Assist Service 2017
Tasmanian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS)
Tasmanian Drug Trends 2006: Findings from the Illicit Drug Reporting System and Extension Study (IDRS-E)
Tasmanian Drug Trends 2007: Findings from the Ilicit Drug Reporting System (IDRS)
Tasmanian Drug Trends 2008: Findings from the Illicit Drug Reporting System (IDRS)
Tasmanian Drug Trends 2009: Findings from the Illicit Drug Reporting System (IDRS)
Tasmanian Drug Trends 2010: Findings from the Illicit Drug Report System (IDRS)
Tasmanian Drug Trends 2011: Findings from the Illicit Drug Reporting System (IDRS)
Tasmanian drug trends 2013. Findings from the Illicit Drug Reporting System (IDRS)
Tasmanian drug trends 2014. Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No. 131
The blood borne virus transmission risk assessment questionnaire (short version): Can it identify risk equivalently for heroin, methamphetamine and pharmaceutical opioid injectors?; APSAD 2009 Conference
The correlates of financial strain amongst people who inject drugs; APSAD 2012 Conference
The Health and Wellbeing of a Group of Tasmanian Regular Injecting Drug Users
The Health Economics of Haemochromatosis
The impact of increasing severity of hereditary haemochromatosis on health state utility values; Value in Health
Up, up and away: The growth of after-hours MBS claims; Australian Family Physician
What Value GP Assist? The comparative benefits of, and satisfaction with GP Assist in Residential Aged Care Facilities and General Practice in Rural and Urban Tasmania

Research Projects

GP Assist

Research Candidate Supervision